|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
4/21/2006 12:15:03 PM
SALT LAKE CITY--(BUSINESS WIRE)--April 20, 2006--ZEVEX International Inc. (NASDAQ: ZVXI - News), developer and manufacturer of high-quality, high-value medical products, announced today that its board of directors has approved a 3-for-2 stock split on all shares of its outstanding common stock, that will be effected in the form of a 50% stock dividend. The dividend will entitle all stockholders on record, as of the close of business on May 4, 2006, to receive one additional share of common stock for every two shares of common stock held at such time. The additional shares will be distributed to all stockholders on or about May 19, 2006. Currently, the company has approximately 3.6 million shares of common stock outstanding. After giving effect to the stock split, the company will have approximately 5.5 million shares of common stock outstanding. The board of directors believes the stock split reflects its confidence in the outlook for ZEVEX, and that the increase in outstanding shares will enhance the trading of the company's stock.
|
|
|
|
|
|
|
|
|
|
|